Xcout Intel
ARADIGM CORP
Aradigm Corp is a specialty pharmaceutical company headquartered in Hayward, California, focused on the development and manufacturing of innovative drug delivery technologies.
Subscribe to see ARADIGM CORP’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
ARADIGM CORP at a glance
ARADIGM CORP is a pharmaceuticals company headquartered in United States. Its most recent funding round, Series A, raised $20M in December 2025. Xcout tracks 20 named people at ARADIGM CORP, including Will Shrank, M.D. (CEO).
ARADIGM CORP leadership
- Will Shrank, M.D.CEO
- SPENCER CARRUCCIUChief Product Officer
- William ShrankCEO and Co-Founder
- Alec KingstonGrowth & Partnerships
- Annie CollinsCommercial
- Bryan KnightEngineering
14 more named people on record for ARADIGM CORP, with roles, board committees and tenure — see the full roster →
ARADIGM CORP funding rounds
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Series A | $20M | 3 named | |
| Series A | $5M | 3 named | |
| SEC Form D filing | $23M | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Investors
ARADIGM CORP competitors
A few of ARADIGM CORP's closest competitors — see the full list of competitors and alternatives →
Ventaira Pharmaceuticals, formerly known as BattellePharma, is a United States-based specialty pharmaceutical company established in 1997 that specializes in developing, manufacturing, and marketing pharmaceuticals and veterinary medicine. The company utilizes proprietary pulmonary drug delivery technology, such as the Mystic system, to develop inhaled products.
AcelRx Pharmaceuticals, Inc. is a specialty pharmaceutical company based in San Mateo and Redwood City, California, focused on developing and commercializing therapeutic products.
Chiesi Farmaceutici is a global biopharmaceutical group that researches, develops, and commercializes therapeutic solutions for patients. The company focuses primarily on respiratory health, rare diseases, and specialty care.
Azurity Pharmaceuticals is a U.S.-based specialty pharmaceutical company that develops and commercializes medicines for underserved patient populations, including treatments for rare diseases and complex conditions. It focuses on patient-friendly dosage forms and serves healthcare providers, patients, and caregivers, including pediatric and other populations with unmet medication needs.
Crossject SA is an emerging specialty pharmaceutical company based in France and the U.S. that focuses on advanced regulatory and needle-free injection technologies. Headquartered in Dijon, France, the firm develops innovative drug delivery systems.
Founded in 2003, Nexus Pharmaceuticals is a US-based, family-owned, and minority-led pharmaceutical manufacturer that specializes in innovative processes to produce difficult-to-manufacture injectable drugs.
Get ARADIGM CORP's news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on ARADIGM CORP in Xcout Intel
- 20 named people with titles, LinkedIn and board committees
- 3 funding rounds with the investors in each, and who they co-invest with
- The full competitor set, tracking, exports and API access